India markets closed

Ontrak, Inc. (OTRK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.89+0.69 (+2.08%)
As of 1:44PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close33.20
Open33.42
Bid33.74 x 1000
Ask34.01 x 900
Day's range33.04 - 34.23
52-week range20.20 - 99.89
Volume92,647
Avg. volume368,909
Market cap621.305M
Beta (5Y monthly)2.35
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date03-Aug-2021 - 09-Aug-2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est40.86
  • Investors in NASDAQ: OTRK shares should contact the Shareholders Foundation in connection with the lawsuit against Ontrak, Inc.
    GlobeNewswire

    Investors in NASDAQ: OTRK shares should contact the Shareholders Foundation in connection with the lawsuit against Ontrak, Inc.

    SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ: OTRK shares. Investors, who purchased shares of Ontrak, Inc. (NASDAQ: OTRK) in October 2020 or earlier and continue to hold any of their NASDAQ: OTRK shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The plaintiff alleged that the defendants failed to disclose to investors that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings, that, as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak, that, because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Those who purchased Ontrak, Inc. (NASDAQ: OTRK) shares should contact the Shareholders Foundation, Inc. CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108 The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

  • Optima Health Selects Ontrak for all Medicare and Medicaid Business
    Business Wire

    Optima Health Selects Ontrak for all Medicare and Medicaid Business

    Ontrak, Inc (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced a new Master Services Agreement with Sentara Healthcare for the expansion of its Ontrak program for Optima Health members. This expansion ensures that all eligible Medicare and Medicaid members of the health plan will have access to critical behavioral healthcare.

  • Ontrak to Present at the 2021 RBC Capital Markets Global Healthcare Conference
    Business Wire

    Ontrak to Present at the 2021 RBC Capital Markets Global Healthcare Conference

    Ontrak, Inc (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced the company will be participating in the upcoming RBC Capital Markets Global Healthcare Conference.